Irish drug research company to list on AIM

A CORK drug research company will complete its journey from UCC start-up to the London Stock Exchange early next month.

EiRx Therapeutics, which develops drugs that target cancer and inflammatory disease, will list on the Alternative Investment Market for smaller and developing companies on January 5.

The company was founded in 1999 by Professor Tom Cotter, head of biochemistry at UCC, and conducts research into the area of apoptosis, which relates to the process of cells dying naturally.